PATENT CLAIM ANALYSIS

Application Number: 15904614
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "009100"]

Abstract:
The method provides methods and compositions for treating metabolic disorders such as impaired glucose tolerance, elevated blood glucose, insulin resistance, dyslipidemia, obesity, and fatty liver.

Claim (Index 8):
The method of  claim 1 , wherein the functional fragment of FGF-1 is administered once per day.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.24
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14184621', '14526058', '15703717', '15240803', '14731705']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8642355368492413
- 35 USC 102 Novelty (BERT): 0.639481568383126
- Combined Prediction Score: 0.8417601400026297
- Mean Citation Score: 611.7198980000003
- Max Citation Score: 612.96643
- Similarity Product: 567.8572193083637

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test